Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. AstraZeneca PLC (AZN)

  7. AstraZeneca PLC (AZN) Financials

AZN

AstraZeneca PLC

54.17
0.00 (0.0%)
Upgrade to Real-Time

AstraZeneca PLC (AZN) Fundamentals
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its revenue.
SHARE INFORMATION
Market Cap$ 192,128,098,228
Shares Outstanding3,098,840,294
Float3,097,023,796
Percent Float99.94%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 1.40
Latest Fiscal Revenue$ 34,090,615,163
Latest Fiscal EPS$ 0.13
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date2022-02-24
Dividend Rate$ 1.93
Dividend Yield3.11%
Payment CashCash
HOLDERS
Institutions1,554
Institutional Holdings Date2022-02-28
Institutional Bought Previous 3 Months98,189,037
Institutional Holdings Percent34.3%
Institutional Sold Previous 3 Months98,378,436
Insider Holdings Date2022-01-31
Insider Bought Previous 3 Months3,554
Insider Holdings Percent0.1
Insider Sold Previous 3 Months-
Insider Shares Owned1,816,498
TRADING INFO
52 Week High$ 64.21
52 Week Low$ 46.48
52 Week High Change$ 33.04
21 Day Moving Average$ 58.3701
21 Day Extended Moving Average$ 59.6548
50 Day Moving Average$ 57.7072
50 Day Extended Moving Average$ 58.8472
200 Day Moving Average$ 57.3918
200 Day Extended Moving Average$ 57.5596
10 Day Average Volume10,703,069
20 Day Average Volume9,680,832
30 Day Average Volume8,862,436
50 Day Average Volume6,944,594
Alpha0.011603
Beta0.4603
Standard Deviation0.062229
R20.113094
7 Day Price Change$ 2.43
7 Day Percent Change4.07%
21 Day Price Change$ 5.71
21 Day Percent Change10.15%
30 Day Price Change$ 3.93
30 Day Percent Change6.77%
Month to Date Price Change$ 1.12
Month to Date Percent Change1.84%
Quarter to Date Price Change$ 4.68
Quarter to Date Percent Change8.16%
180 Day Price Change$ 3.36
180 Day Percent Change5.73%
200 Day Price Change$ 4.45
200 Day Percent Change7.74%
Year to Date Price Change$ 4.68
Year to Date Percent Change8.16%

AstraZeneca PLC (AZN) Key Ratios

PROFITABILITY
EBIT Margin2.7%
EBITDA Margin20.2%
Pre-Tax Profit Margin6.9%
Profit Margin Count0.22%
Gross Margin66.8%
Profit Margin TOT0.22%
INCOME STATEMENTS
Revenue$ 33,741,108,517
Revenue Per Share$ 10.8883
Revenue (3 Years)$ 16.38
Revenue (5 Years)$ 7.90
FINANCIAL STRENGTH
Price to Tangible Book-8.20
Total Debt To Equity0.80
Int Coverage0.80
Current Ratio1.20
Leverage Ratio3.20
Quick Ratio0.30
Long Term Debt To Capital0.42
VALUATION MEASURES
PE Ratio487.00
Enterprise Value$ 215,479,401,406
Price to Sales5.6942
Price to Free Cash-19.80
PE High Last 5 Years126.10
Price To Book4.80
Price To Cash Flow29.10
PE Low Last 5 Years19.20
Price to Tangible Book-8.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover2.00
Assets Turnover0.40
Return Assets0.13
Return on Equity0.42
Return on Capital2.09

AstraZeneca PLC (AZN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeDR
Auditor-
CEOPascal Soriot
Employees76100
Last Audit-
CIK0000901832
IndustryDrug Manufacturers
SectorHealthcare
NAICS-
CONTACT INFO
Address1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge, CB2 0AA
Websitehttp://www.astrazeneca.com
Facsimile+44 1223352858
Telephone+44 2037495000
Emailir@astrazeneca.com


Your Recent History
NYSE
AZN
AstraZenec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.